US: +1 646-781-8004 | Europe:+44-203-868-8738 | APAC:+91-744-778-0008

Immunoassay Market

Release date:

Jun-2021

Region:

global

Research Code:MRHC - 104278

Sku:MRHC - 104278

Immunoassay Market by Product & Solutions (Immunoassay Kits {ELISA, Rapid Tests}, Immunoassay Analyzers, Software & Services), Platform (Chemiluminescence, Radioimmunoassay), Application (Infectious Diseases, Oncology, Allergy), End User - Forecast to 2028

  • Report ID: MRHC - 104278
  • Pages: 248
  • Jun-2021
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours
COVID-19

This report provides pre & post COVID-19 market estimates.

The immunoassay market is expected to reach $46.5 billion by 2028, at a CAGR of 7.5% during the forecast period of 2021 to 2028. The increasing prevalence of acute and chronic infectious diseases coupled with the rising geriatric population, growing awareness for early disease diagnosis, technological advancements in immunoassays, increasing use of immunoassays in oncology and drug & alcohol testing, and the emergence of COVID-19 are the key factors driving the growth of the immunoassays market. In addition, increasing epidemic potentials, integration of microfluidics technology into immunoassays, and emerging economies offer significant growth opportunities for the players operating in this market.

Impact of COVID-19 on the Immunoassays Market

The COVID-19 pandemic has adversely hit many economies around the globe. The pandemic has affected more than 100 countries. In this global pandemic, although many dedicated healthcare professionals are working tirelessly against this crisis, it is important to minimize disease spread by preparing kits for early diagnosis. Testing is one of the essential tools in understanding and managing the coronavirus. As molecular diagnostic tests such as PCR cannot be used to monitor disease progression, there is a greater demand for immunological assays.

Further, the COVID-19 outbreak has impacted the immunoassays market in three areas, i.e., price impact, impact on demand, and impact on the supply chain.

  • Price Impact: The need for immunoassay kits for reliable COVID 19 testing has urged governments in many countries to bring down these test prices, making them affordable for everyone. In some government laboratories, these kits are available free of cost. Because of the pandemic, there is an expansion in the adoption of immunoassay products even though there is a reduction in these kits' prices.
  • Effect on Demand: Due to the disadvantages conferred by the molecular assays, there is greater demand for immunoassays. Further, immunoassays have a vital part to play in vaccine development, thereby increasing its demand. For instance, lateral flow immunoassays are the rapid diagnostic tests used to detect viral antigens within 10-30 minutes.
  • Effect on the Supply Chain: Due to the emergence of COVID-19, several impositions have been laid down by government bodies in several countries, including lockdown leading to the ban of goods throughout the country’s borders. This has led to a shortage in the supply of immunoassay kits. Although there was a disruption in the supply chain, companies were able to maintain the supply chain due to government bodies and manufacturers' joint efforts.

Amidst the pandemic, manufacturers are contributing by developing various diagnostic kits and assays for early disease diagnosis, driving the growth of the immunoassay market. For instance, in February 2021, Agilent Technologies Inc. (U.S.) launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit used for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.

Immunoassay Market

                                                            Click here to: Get Free Sample Pages of this Report 

Technological advancements in immunoassay techniques are propelling the growth of the immunoassays market

ELISA is the most widely used immunoassay technique for the diagnosis of infectious diseases. This technique is used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Some examples include diagnosis of HIV infection, pregnancy tests, and measurement of cytokines or soluble receptors in cell supernatant or serum.

With the development of signal generation methods, the attention has shifted to the development of immunochemical methods and instruments to provide convenient, high-performance systems. Important advances have been made in the design of immunochemical approaches that allow small molecules, such as metabolites and toxins, to substitute dynamic format assays with non-competitive formats, bringing advantages previously seen only with large molecular analytes. Further, the continuous development of new biomarkers, cost-benefit, and growing adoption of automated platforms for ELISA are expected to increase this technology's adoption.

Bispecific antibodies and recombinant proteins are also beginning to impact immunodiagnostics. Due to the growing acceptance of smart devices, companies are developing automated lateral flow readers connected to mobile phones or laptops. They can produce highly sensitive and quantifiable results, capture and transmit real-time data. Also, there has been high adoption of smart devices in healthcare systems for analysis and data management.

Integration of microfluidics technology in immunoassays offer lucrative growth opportunities

Immunoassays have long been widely used in various applications, such as medical diagnostics, pharmaceutical analysis, environmental, food safety testing, and basic scientific investigations, because of their simplicity, sensitivity, and specificity. However, most immunoassays include a series of washing, mixing, and incubation steps, which are labor-intensive and time-consuming.

Immunoagents used in immunoassays are relatively expensive. The consumption of the immunoagents can be greatly reduced if the system is miniaturized. Therefore, microfluidic systems, also known as a lab-on-a-chip or a micro-total-analysis-system, have attracted a lot of attention due to their advantages, such as miniaturization, integration, and automation.

Microfluidic devices are a new and diverse technology that uses fluids in micro environments in a controlled manner, distinguishing them from conventional nitrocellulose lateral flow tests. They can be regarded as the ultimate technical solution for miniaturizing protein biomarker immunoassays by uniquely combining the advantages of simplified fluidics, a reduced number of reagents, and much shorter assay times. These devices have used several methods for antibody immobilization, including passive adsorption, which is common with plastic surfaces, covalent binding, where salinization seems to be the base of most covalent binding techniques, and a combination of the two techniques together with some antibody-orientated techniques, which are still not widely used.

Microfluidic protein quantitation is a promising area for the POC diagnosis of non-communicable diseases and severe infections, such as sepsis. Diagnosing these health conditions requires the accurate quantitation of very small amounts of biomarkers present in biological samples. Thus, the integration of microfluidics technology in immunoassay is expected to provide lucrative opportunities for the growth of the immunoassays market.

Key Findings of the Global Immunoassays Market Study:

The ELISA kits and reagents segment is expected to account for the largest share during the forecast period.

Increasing prevalence of infectious diseases such as HIV, growing awareness regarding the diagnosis of cancer and autoimmune diseases, and emergence of the coronavirus pandemic are the factors leading to the growth of the segment.

The chemiluminescence immunoassays segment is expected to grow at the highest CAGR during the forecast period.

Rising trends towards adoption of chemiluminescence assays in clinical diagnostics, research applications, and pharmaceutical analysis due to their low cost per test are the factors majorly responsible for the growth of this segment during the forecast period.

Based on application, the bone and mineral diseases segment is expected to grow at the highest CAGR during the forecast period.

The rising need for the early diagnosis of osteoporosis and monitoring the effectiveness of the treatment and growing demand for vitamin D testing are the factors driving the growth of this segment.

In 2021, the diagnostic reference laboratories segment is expected to account for the largest share of the immunoassays market.

Factors contributing to the large share of this segment include the rising laboratory automation, availability of well-equipped systems, growing prevalence of infectious diseases, and rising government initiatives to increase the adoption of immunoassay techniques in diagnostic reference laboratories.

Asia Pacific: Fastest Growing Market

At the regional level, North America is expected to account for the largest share of the immunoassays market in 2021. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The growth in this market is expected to be driven by the increasing prevalence of infectious diseases and cancer, increasing government spending on healthcare, and improved diagnosis and treatment access.

Key Players

The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the past four years. The key players profiled in the global immunoassay market are F. Hoffman-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.) and PerkinElmer, Inc. (U.S.)  among others.

Scope of the Report:

Immunoassays Market, by Product & Solution

  • Immunoassay Kits and Reagents
    • Elisa Kits and Reagents
    • Rapid Test Kits and Reagents
    • Western Blot Kits and Reagents
    • Elispot Kits and Reagents
    • Other Immunoassay Kits and Reagents
  • Immunoassay Analyzers
  • Immunoassay Software and Services
    (Other immunoassay kits and reagents comprises radioimmunoassay, microarray immunoassays, immunohistochemistry assays, bead-based immunoassays, and multiplex microarray assays)

Immunoassays Market, by Platform

  • Chemiluminescence Immunoassay
  • Fluorescence Immunoassay
  • Colorimetric Immunoassay
  • Radioimmunoassay
  • Other Immunoassay Platforms
    (Other immunoassay platforms comprise turbidimetric immunoassays, chromatographic immunoassays, microarray immunoassays, immunohistochemistry, and counting immunoassays)

Immunoassays Market, by Application

  • Infectious Diseases
  • Oncology
  • Endocrinology
  • Cardiology
  • Bone and Mineral Diseases
  • Autoimmune Disorders
  • Other Applications
    (Other applications comprise toxicology, hematology, neonatal testing, allergy, and gastrology.)

Immunoassay Market, by End User

  • Diagnostics Reference Laboratories
  • Hospitals and Clinics
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Other End Users
    (Other end users comprise nursing homes, ambulatory care centers, blood banks, and home healthcare agencies)

Immunoassays Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • Indonesia
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Key questions answered in the report:

What is the focus of the immunoassays market?

The immunoassays market covers the market size & forecasts of consumables like kits and reagents, immunoassay analyzers, and software & services. The immunoassays market studied in this report involves the value analysis of various segments and sub-segments of immunoassays at the regional and country level.

What is the value of revenue generated from the sale of immunoassay solutions across the globe? At what rate their demand expected to grow for the next 5-7 years?

The global immunoassays market is projected to reach $46.50 billion by 2028, at a CAGR of 7.5% during the forecast period.

Based on product and solution, which segment is estimated to hold the major share of the market?

The immunoassay kits and reagents segment is expected to account for the largest share of the immunoassays market in 2021.

Which platform is projected to create more traction in the global immunoassay market?

Based on platform, the chemiluminescence immunoassays segment is projected to create more traction due to the increase in the adoption of chemiluminescence assays in clinical diagnostics, research applications, and pharmaceutical analysis.

What are the key factors supporting the growth of this market? What are the major opportunities for existing market players and new entrants in the global immunoassays market?

An increase in the spread of various chronic and infectious diseases, technological advancements in immunoassays, increasing use of immunoassays in oncology and drug & alcohol testing, and the emergence of COVID-19 are the factors supporting the growth of the immunoassay market. Further, the increasing epidemic potentials, integration of microfluidics technology into immunoassays, and emerging economies offer lucrative growth opportunities for the players operating in this market.

Who are the major players operating in the global immunoassays market?

The key players operating in the global immunoassay market are F. Hoffman-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.) and PerkinElmer, Inc. (U.S.) among others.

Which regions/countries are likely to offer significant growth opportunities for the vendors in this market during the analysis period?

The emerging countries from Asia and Latin America are projected to offer significant growth opportunities for the vendors in this market.

1.    Introduction 
       1.1.    Market Definition 
       1.2.    Market Ecosystem 
       1.3.    Currency 
       1.4.    Key Stakeholders 

2.    Research Methodology 
       2.1.    Research Process 
       2.2.    Data Collection & Validation 
                 2.2.1.    Secondary Research 
                2.2.2.    Primary Research 
       2.3.    Market Assessment 
                2.3.1.    Market Size Estimation 
                             2.3.1.1.    Bottom-Up Approach 
                             2.3.1.2.    Top-Down Approach 
                             2.3.1.3.    Growth forecast 
                2.3.2.    Market Share Analysis 
       2.4.    Assumptions for the Study 
       2.5.    Limitations for the Study 

3.    Executive Summary 

4.    Market Insights 
       4.1.    Introduction 
       4.2.    Drivers 
                4.2.1.    Growing Prevalence of Chronic and Infectious Diseases 
                4.2.2.    Technological Advancements in Immunoassays 
                4.2.3.    Increasing Use of Immunoassays in Oncology 
                4.2.4.    Role of Immunoassays in Drug and Alcohol Testing 
                4.2.5.    Impact of COVID-19 
       4.3.    Restraints 
                4.3.1.    Technical Impediments Concerned with Immunoassay kits 
                4.3.2.    Inadequate Reimbursement Policies for Immunoassays in the U.S. and Europe 
       4.4.    Opportunities 
                4.4.1.    Emerging Economies 
                4.4.2.    Integration of Microfluidics Technology in Immunoassays 

5.    Immunoassays Market – Regulatory Analysis 
       5.1.    North America 
       5.2.    Europe 
       5.3.    Asia-Pacific
       5.4.    Latin America and the Middle East & Africa 

6.    Global Immunoassays Market, by Product & Solution 
       6.1.    Introduction 
       6.2.    Immunoassay Kits & Reagents 
                6.2.1.    Elisa Kits & Reagents 
                6.2.2.    Rapid Test Kits & Reagents 
                6.2.3.    Western Blot Kits & Reagents 
                6.2.4.    Elispot Kits & Reagents 
                6.2.5.    Other Immunoassay Kits & Reagents 
       6.3.    Immunoassay Analyzers 
       6.4.    Immunoassay Software & Services 

7.    Global Immunoassays Market, by Platform 
       7.1.    Introduction 
       7.2.    Chemiluminescence Immunoassay 
       7.3.    Fluorescence Immunoassay 
       7.4.    Colorimetric Immunoassay 
       7.5.    Radioimmunoassay 
       7.6.    Other Immunoassay Platforms

8.    Global Immunoassays Market, by Application 
       8.1.    Introduction 
       8.2.    Infectious Diseases 
       8.3.    Oncology 
       8.4.    Endocrinology 
       8.5.    Cardiology 
       8.6.    Bone and Mineral Diseases        
       8.7.    Autoimmune Disorders 
       8.8.    Other Applications 

9.    Global Immunoassays Market, by End User 
       9.1.    Introduction 
       9.2.    Diagnostic Reference Laboratories 
       9.3.    Hospitals & Clinics 
       9.4.    Pharmaceutical and Biotechnology Companies 
       9.5.    Academic and Research Institutions 
       9.6.    Other End Users 

10.    Immunoassays Market, by Geography 
         10.1.    Introduction 
         10.2.    North America 
                    10.2.1.    U.S. 
                    10.2.2.    Canada 
         10.3.    Europe 
                    10.3.1.    Germany 
                    10.3.2.    Italy 
                    10.3.3.    France 
                    10.3.4.    U.K. 
                    10.3.5.    Spain 
                    10.3.6.    Rest of Europe (RoE) 
         10.4.    Asia-Pacific 
                    10.4.1.    Japan 
                    10.4.2.    China 
                    10.4.3.    India 
                    10.4.4.    Australia 
                    10.4.5.    Indonesia 
                    10.4.6.    Rest of Asia-Pacific (RoAPAC) 
         10.5.    Latin America 
                    10.5.1.    Brazil 
                    10.5.2.    Mexico 
                    10.5.3.    Rest of Latin America 
         10.6.    Middle East and Africa 

11.    Competitive Landscape 
         11.1.    Introduction 
         11.2.    Key Growth Strategies 
         11.3.    Competitive Benchmarking 
         11.4.    Market Share Analysis (2020) 
                    11.4.1.    F. Hoffmann-La Roche AG (SWITZERLAND) 
                    11.4.2.    Abbott Laboratories (U.S.) 
                    11.4.3.    Siemens Healthineers AG (GERMANY) 

12.    Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
         12.1.    F. Hoffmann-La Roche AG 
         12.2.    Siemens Healthineers AG (Subsidiary of Siemens AG) 
         12.3.    Abbott Laboratories 
         12.4.    Danaher Corporation 
         12.5.    Sysmex Corporation 
         12.6.    bioMérieux SA
         12.7.    Thermo Fisher Scientific Inc. 
         12.8.    Becton, Dickinson and Company 
         12.9.    Merck KGaA          
         12.10.    Bio-Rad Laboratories, Inc. 
         12.11.    Agilent Technologies, Inc. 
         12.12.    PerkinElmer, Inc. 

13.    Appendix 
         13.1.    Questionnaire 
         13.2.    Available Customization 

List of Tables

Table 1    Global Immunoassays Market Drivers: Impact Analysis (2021-2028) 
Table 2    Immunoassays for Tumor Markers Analysis 
Table 3    Immunological Tests Used to Detect SARS-Cov-2 Virus 
Table 4    Global Immunoassays Market Restraints: Impact Analysis (2021-2028) 
Table 5    Common Problems with Immunoassays 
Table 6    Reimbursement for Few Immunoassays in the U.S. 
Table 7    Microfluidic Heterogeneous Immunoassays for Protein Biomarkers Quantitation 
Table 8    Policy/Guidelines/Standards in Europe 
Table 9    Immunoassay Regulations in Asia-Pacific Region 
TABLE 10    Immunoassay Regulations in the Rest of the World 
Table 11    GLOBAL Immunoassays Market Size, by Product & Solution, 2019–2028 
(USD MILLION) 
Table 12    Types of Reagents Used in Immunoassays 
Table 13    Global Immunoassay Kits & Reagents Market Size, by Type, 2019–2028 
(USD Million) 
Table 14    Immunoassay Kits & Reagents Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 15    Key Companies Offering Elisa Kits & Reagents 
Table 16    ELISA Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 17    Key Companies Offering Rapid Test Kits & Reagents 
Table 18    Rapid Test Kits & Reagents Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 19    Key Companies Offering Western Blot Kits & Reagents 
Table 20    Western Blot Kits & Reagents Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 21    ELISPOT Vs. Conventional ELISA 
Table 22    Key Companies Offering ELISPOT Kits & Reagents 
Table 23    ELISPOT Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 24    Other Immunoassay Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 25    Some of the Key Companies Offering Immunoassay Analyzers 
Table 26    Immunoassay Analyzers Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 27    Some of the Key Commercial Immunoassay Software Available in the Global Market 
Table 28    Immunoassay Software & Services Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 29    GLOBAL Immunoassays Market Size, by Platform, 2019–2028 (USD MILLION) 
Table 30    Key Companies Offering Chemiluminescence Immunoassay Products 
Table 31    Chemiluminescence Immunoassay Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 32    Key Companies Offering Fluorescence Immunoassay Products 
Table 33    Fluorescence Immunoassay Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 34    Key Companies Offering Colorimetric Immunoassay Products 
Table 35    Colorimetric Immunoassay Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 36    Key Companies Offering Radioimmunoassay Kits & Reagents 
Table 37    Radioimmunoassay Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 38    Other Immunoassay Platforms Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 39    Global Immunoassays Market Size, by Application, 2019–2028 (USD Million) 
Table 40    Rapid Tests for Detecting COVID-19 
Table 41    Global HIV Prevalence, by Region (2019) 
Table 42    Immunoassays Market Size for Infectious Diseases, by Country/Region, 2019–2028 (USD Million) 
Table 43    Global Cancer Incidence and Mortality, by Type (2020) 
Table 44    Immunoassays Market Size for Oncology, by Country/Region, 2019–2028 
(USD Million) 
Table 45    Immunoassays Market Size for Endocrinology, by Country/Region, 2019–2028 
(USD Million) 
Table 46    Immunoassays Market Size for Cardiology, by Country/Region, 2019–2028 
(USD Million) 
Table 47    Immunoassays Market Size for Bone and Mineral Diseases, by Country/Region, 2019–2028 (USD Million) 
Table 48    Immunoassays Market Size for Autoimmune Disorders, by Country/Region, 
2019–2028 (USD Million) 
Table 49    Immunoassays Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million) 
Table 50    Global Immunoassays Market Size, by End User, 2019–2028 (USD Million) 
Table 51    Immunoassays Market Size for Diagnostic Reference Laboratories, 
By Country/Region, 2019–2028 (USD Million) 
Table 52    Immunoassays Market Size for Hospitals & Clinics, by Country/Region, 
2019–2028 (USD MILLION) 
Table 53    Immunoassays Market Size for Pharmaceutical and Biotechnology Companies, 
By Country/Region, 2019–2028 (USD Million) 
Table 54    Immunoassays Market Size for Academic and Research Institutions, 
By Country/Region, 2019–2028 (USD Million) 
Table 55    Immunoassays Market Size for Other End Users, by Country/Region, 2019–2028 (USD Million) 
Table 56    Global Immunoassays Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 57    North America: Immunoassays Market Size, by Country, 2019 – 2028 
(USD Million) 
Table 58    North America: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million) 
Table 59    North America: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million) 
Table 60    North America: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 61    North America: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 62    North America: Immunoassays Market Size, by End User, 2019 – 2028 
(USD Million) 
Table 63    Recent Lateral Flow Assays Product Launches for COVID-19 Testing in U.S. 
Table 64    U.S.: Immunoassays Market Size, by Product & Solution, 2019 – 2028 
(USD Million) 
Table 65    U.S.: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 66    U.S.: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 67    U.S.: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 68    U.S.: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 69    Canada: Immunoassays Market Size, by Product & Solution, 2019 – 2028 
(USD Million) 
Table 70    Canada: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 71    Canada: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 72    Canada: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 73    Canada: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 74    Europe: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million) 
Table 75    Europe: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 76    Europe: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 77    Europe: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 78    Europe: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 79    Europe: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 80    Recent Immunoassay Kits Launched for COVID-19 Testing In Germany 
Table 81    Germany: Immunoassays Market Size, By Product & Solutions, 2019 – 2028 
(USD Million) 
Table 82    Germany: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 83    Germany: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 84    Germany: Immunoassay Market Size, by Application, 2019 – 2028 (USD Million) 
Table 85    Germany: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 86    Number Of Cancer Cases, (2019 vs. 2040) 
Table 87    Italy: COVID-19 Cases 
Table 88    Italy: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 89    Italy: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 90    Italy: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 91    Italy: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 92    Italy: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 93    France: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 94    France: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 95    France: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 96    France: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 97    France: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 98    Number of Acute Respiratory Illness Outbreaks in the U.K. by Institution Type: 2015-2019 
Table 99    U.K.: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 100    U.K.: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 101    U.K.: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 102    U.K.: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 103    U.K.: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
 Table 104    Spain: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 105    Spain: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD MILLION) 
Table 106    Spain: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 107    Spain: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 108    Spain: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 109    COVID-19 Cases in European Countries 
Table 110    RoE: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 111    RoE: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 112    RoE: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 113    RoE: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 114    RoE: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 115    Asia-Pacific: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million) 
Table 116    Asia-Pacific: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million)
Table 117    Asia-Pacific: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million) 
Table 118    Asia-Pacific: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 119    Asia-Pacific: Immunoassay Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 120    Asia-Pacific: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 121    Japan: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 122    Japan: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 123    Japan: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 124    Japan: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 125    Japan: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 126    China: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 127    China: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 128    China: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 129    China: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 130    China: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 131    India: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 132    INDIA: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 133    India: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 134    India: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 135    India: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 136    Australia: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 137    Australia: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 138    Australia: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 139    Australia: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 140    Australia: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 141    Indonesia: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 142    Indonesia: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 143    Indonesia: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 144    Indonesia: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 145    Indonesia: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 146    RoAPAC: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 147    RoAPAC: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 148    RoAPAC: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 149    RoAPAC: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 150    RoAPAC: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 151    Latin America: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million) 
Table 152    Latin America: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million) 
Table 153    Latin America: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million) 
Table 154    Latin America: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 155    Latin America: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 156    Latin America: Immunoassays Market Size, by End User, 2019 – 2028 
(USD Million) 
Table 157    Brazil: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 158    Brazil: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 159    Brazil: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 160    Brazil: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 161    Brazil: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 162    Some Immunoassays Validated by the National Institute for Epidemiological Diagnosis and Reference (Indre) in Mexico 
Table 163    Mexico: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 164    Mexico: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 165    Mexico: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 166    Mexico: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 167    Mexico: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 168    Disease Prevalence and top Causes of Deaths (2019) 
Table 169    Rest of Latin America: Immunoassays Market Size, by Product & Solutions, 
2019 – 2028 (USD Million) 
Table 170    Rest of Latin America: Immunoassay Kits and Reagents Market Size, by Type, 
2019 – 2028 (USD Million) 
Table 171    Rest of Latin America: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 172    Rest of Latin America: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 173    Rest of Latin America: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 174    Middle East & Africa: Immunoassays Market Size, by Product & Solutions, 
2019 – 2028 (USD Million) 
Table 175    Middle East & Africa: Immunoassays Kits and Reagents Market Size, by Type, 
2019 – 2028 (USD Million) 
Table 176    Middle East & Africa: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 177    Middle East & Africa: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 178    Middle East & Africa: Immunoassays Market Size, by End User, 2019 – 2028 
(USD Million) 
Table 179    Recent Developments, by Company, 2018—2021 

List of Figures

Figure 1    Research Process 
Figure 2    Key Secondary Sources 
Figure 3    Primary Research Techniques 
Figure 4    Key Executives Interviewed 
Figure 5    Breakdown of Primary Interviews (Supply-Side & Demand-Side) 
Figure 6    Market Size Estimation 
Figure 7    Global Immunoassays Market Size, by Product & Solution, 2021 vs. 2028 
(USD Million) 
Figure 8    Global Immunoassays Market Size, by Platform, 2021 vs. 2028 (USD Million) 
Figure 9    Global Immunoassays Market Size, by Application, 2021 vs. 2028 (USD Million) 
Figure 10    Diagnostic Reference Laboratories to Dominate the Immunoassays Market, 
by End User (2021 vs. 2028) 
Figure 11    Immunoassays Market, by Region 
Figure 12    Market Dynamics 
Figure 13    Global Diabetes Prevalence by Age and Sex in 2019 
Figure 14    Global Immunoassays Market Size, by Product & Solution, 2021–2028 (USD Million) 
Figure 15    Number of People Living with HIV Worldwide, 2015–2019 (Million) 
Figure 16    Global Immunoassays Market Size, by Platform, 2021–2028 (USD Million) 
Figure 17    Global Immunoassays Market Size, by Application, 2021–2028 (USD Million) 
Figure 18    Global Immunoassays Market Size, by End User, 2021–2028 (USD Million) 
Figure 19    Hospital Admissions Due to COVID-19 (2020–2021) 
Figure 20    Global Immunoassays Market, by Region, 2021 – 2028 (USD Million) 
Figure 21    Geographic Snapshot: North American Immunoassays Market 
Figure 22    Geographic Snapshot: European Immunoassays Market 
Figure 23    France: The Share of Older People (65 Years and Above), 2012-2050 
Figure 24    Geographic Snapshot: Asia-Pacific Immunoassays Market 
Figure 25    Japan: Share of Geriatric Population in total Population (65 And Over) 
Figure 26    Key Growth Strategies Adopted by Leading Players, 2018—2021 
Figure 27    Immunoassays Market: Competitive Benchmarking, by Product 
Figure 28    Market Share Analysis: Immunoassays Industry, 2020 
Figure 29    F. Hoffmann-La Roche AG: Financial Overview, 2020 
Figure 30    Siemens Healthineers AG.: Financial Overview, 2020 
Figure 31    Abbott Laboratories.: Financial Overview, 2020 
Figure 32    Danaher Corporation: Financial Overview, 2020 
Figure 33    Sysmex Corporation.: Financial Overview, 2020 
Figure 34    bioMérieux SA: Financial Overview, 2020 
Figure 35    Thermo Fisher Scientific Inc: Financial Overview, 2020 
Figure 36    Becton, Dickinson and Company: Financial Overview, 2020 
Figure 37    Merck KGaA: Financial Overview, 2020 
Figure 38    Bio-Rad Laboratories, Inc.: Financial Overview, 2020 
Figure 39    Agilent Technologies, Inc.: Financial Overview, 2020 
Figure 40    PerkinElmer, Inc.: Financial Overview, 2021 

 
Name can only consist of alphabets.
Please provide your full name.
 
Please provide valid email address.
Please provide your email address.
 
Please provide your job title.
 
Please provide your company name.
 
Please provide your company name.
 
Please provide valid phone number.
Please provide your phone number.
 
Please enter minimum 10 characters.
 
Please enter Captcha.
Please enter valid Captcha.

This website is secure and we do not share your personal information with any third party. Privacy Policy

Related Research

The immunoassay market is expected to reach $46.5 billion by 2028, at a CAGR of 7.5% during the forecast period of 2021 to 2028. The increasing prevalence of acute and chronic infectious diseases coupled with the rising geriatric population, growing awareness for early disease diagnosis, technological advancements in immunoassays, increasing use of immunoassays in oncology and drug & alcohol testing, and the emergence of COVID-19 are the key factors driving the growth of the immunoassays market. In addition, increasing epidemic potentials, integration of microfluidics technology into immunoassays, and emerging economies offer significant growth opportunities for the players operating in this market.

Impact of COVID-19 on the Immunoassays Market

The COVID-19 pandemic has adversely hit many economies around the globe. The pandemic has affected more than 100 countries. In this global pandemic, although many dedicated healthcare professionals are working tirelessly against this crisis, it is important to minimize disease spread by preparing kits for early diagnosis. Testing is one of the essential tools in understanding and managing the coronavirus. As molecular diagnostic tests such as PCR cannot be used to monitor disease progression, there is a greater demand for immunological assays.

Further, the COVID-19 outbreak has impacted the immunoassays market in three areas, i.e., price impact, impact on demand, and impact on the supply chain.

  • Price Impact: The need for immunoassay kits for reliable COVID 19 testing has urged governments in many countries to bring down these test prices, making them affordable for everyone. In some government laboratories, these kits are available free of cost. Because of the pandemic, there is an expansion in the adoption of immunoassay products even though there is a reduction in these kits' prices.
  • Effect on Demand: Due to the disadvantages conferred by the molecular assays, there is greater demand for immunoassays. Further, immunoassays have a vital part to play in vaccine development, thereby increasing its demand. For instance, lateral flow immunoassays are the rapid diagnostic tests used to detect viral antigens within 10-30 minutes.
  • Effect on the Supply Chain: Due to the emergence of COVID-19, several impositions have been laid down by government bodies in several countries, including lockdown leading to the ban of goods throughout the country’s borders. This has led to a shortage in the supply of immunoassay kits. Although there was a disruption in the supply chain, companies were able to maintain the supply chain due to government bodies and manufacturers' joint efforts.

Amidst the pandemic, manufacturers are contributing by developing various diagnostic kits and assays for early disease diagnosis, driving the growth of the immunoassay market. For instance, in February 2021, Agilent Technologies Inc. (U.S.) launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit used for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.

Immunoassay Market

                                                            Click here to: Get Free Sample Pages of this Report 

Technological advancements in immunoassay techniques are propelling the growth of the immunoassays market

ELISA is the most widely used immunoassay technique for the diagnosis of infectious diseases. This technique is used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Some examples include diagnosis of HIV infection, pregnancy tests, and measurement of cytokines or soluble receptors in cell supernatant or serum.

With the development of signal generation methods, the attention has shifted to the development of immunochemical methods and instruments to provide convenient, high-performance systems. Important advances have been made in the design of immunochemical approaches that allow small molecules, such as metabolites and toxins, to substitute dynamic format assays with non-competitive formats, bringing advantages previously seen only with large molecular analytes. Further, the continuous development of new biomarkers, cost-benefit, and growing adoption of automated platforms for ELISA are expected to increase this technology's adoption.

Bispecific antibodies and recombinant proteins are also beginning to impact immunodiagnostics. Due to the growing acceptance of smart devices, companies are developing automated lateral flow readers connected to mobile phones or laptops. They can produce highly sensitive and quantifiable results, capture and transmit real-time data. Also, there has been high adoption of smart devices in healthcare systems for analysis and data management.

Integration of microfluidics technology in immunoassays offer lucrative growth opportunities

Immunoassays have long been widely used in various applications, such as medical diagnostics, pharmaceutical analysis, environmental, food safety testing, and basic scientific investigations, because of their simplicity, sensitivity, and specificity. However, most immunoassays include a series of washing, mixing, and incubation steps, which are labor-intensive and time-consuming.

Immunoagents used in immunoassays are relatively expensive. The consumption of the immunoagents can be greatly reduced if the system is miniaturized. Therefore, microfluidic systems, also known as a lab-on-a-chip or a micro-total-analysis-system, have attracted a lot of attention due to their advantages, such as miniaturization, integration, and automation.

Microfluidic devices are a new and diverse technology that uses fluids in micro environments in a controlled manner, distinguishing them from conventional nitrocellulose lateral flow tests. They can be regarded as the ultimate technical solution for miniaturizing protein biomarker immunoassays by uniquely combining the advantages of simplified fluidics, a reduced number of reagents, and much shorter assay times. These devices have used several methods for antibody immobilization, including passive adsorption, which is common with plastic surfaces, covalent binding, where salinization seems to be the base of most covalent binding techniques, and a combination of the two techniques together with some antibody-orientated techniques, which are still not widely used.

Microfluidic protein quantitation is a promising area for the POC diagnosis of non-communicable diseases and severe infections, such as sepsis. Diagnosing these health conditions requires the accurate quantitation of very small amounts of biomarkers present in biological samples. Thus, the integration of microfluidics technology in immunoassay is expected to provide lucrative opportunities for the growth of the immunoassays market.

Key Findings of the Global Immunoassays Market Study:

The ELISA kits and reagents segment is expected to account for the largest share during the forecast period.

Increasing prevalence of infectious diseases such as HIV, growing awareness regarding the diagnosis of cancer and autoimmune diseases, and emergence of the coronavirus pandemic are the factors leading to the growth of the segment.

The chemiluminescence immunoassays segment is expected to grow at the highest CAGR during the forecast period.

Rising trends towards adoption of chemiluminescence assays in clinical diagnostics, research applications, and pharmaceutical analysis due to their low cost per test are the factors majorly responsible for the growth of this segment during the forecast period.

Based on application, the bone and mineral diseases segment is expected to grow at the highest CAGR during the forecast period.

The rising need for the early diagnosis of osteoporosis and monitoring the effectiveness of the treatment and growing demand for vitamin D testing are the factors driving the growth of this segment.

In 2021, the diagnostic reference laboratories segment is expected to account for the largest share of the immunoassays market.

Factors contributing to the large share of this segment include the rising laboratory automation, availability of well-equipped systems, growing prevalence of infectious diseases, and rising government initiatives to increase the adoption of immunoassay techniques in diagnostic reference laboratories.

Asia Pacific: Fastest Growing Market

At the regional level, North America is expected to account for the largest share of the immunoassays market in 2021. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The growth in this market is expected to be driven by the increasing prevalence of infectious diseases and cancer, increasing government spending on healthcare, and improved diagnosis and treatment access.

Key Players

The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the past four years. The key players profiled in the global immunoassay market are F. Hoffman-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.) and PerkinElmer, Inc. (U.S.)  among others.

Scope of the Report:

Immunoassays Market, by Product & Solution

  • Immunoassay Kits and Reagents
    • Elisa Kits and Reagents
    • Rapid Test Kits and Reagents
    • Western Blot Kits and Reagents
    • Elispot Kits and Reagents
    • Other Immunoassay Kits and Reagents
  • Immunoassay Analyzers
  • Immunoassay Software and Services
    (Other immunoassay kits and reagents comprises radioimmunoassay, microarray immunoassays, immunohistochemistry assays, bead-based immunoassays, and multiplex microarray assays)

Immunoassays Market, by Platform

  • Chemiluminescence Immunoassay
  • Fluorescence Immunoassay
  • Colorimetric Immunoassay
  • Radioimmunoassay
  • Other Immunoassay Platforms
    (Other immunoassay platforms comprise turbidimetric immunoassays, chromatographic immunoassays, microarray immunoassays, immunohistochemistry, and counting immunoassays)

Immunoassays Market, by Application

  • Infectious Diseases
  • Oncology
  • Endocrinology
  • Cardiology
  • Bone and Mineral Diseases
  • Autoimmune Disorders
  • Other Applications
    (Other applications comprise toxicology, hematology, neonatal testing, allergy, and gastrology.)

Immunoassay Market, by End User

  • Diagnostics Reference Laboratories
  • Hospitals and Clinics
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Other End Users
    (Other end users comprise nursing homes, ambulatory care centers, blood banks, and home healthcare agencies)

Immunoassays Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • Indonesia
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Key questions answered in the report:

  Request Sample

1.    Introduction 
       1.1.    Market Definition 
       1.2.    Market Ecosystem 
       1.3.    Currency 
       1.4.    Key Stakeholders 

2.    Research Methodology 
       2.1.    Research Process 
       2.2.    Data Collection & Validation 
                 2.2.1.    Secondary Research 
                2.2.2.    Primary Research 
       2.3.    Market Assessment 
                2.3.1.    Market Size Estimation 
                             2.3.1.1.    Bottom-Up Approach 
                             2.3.1.2.    Top-Down Approach 
                             2.3.1.3.    Growth forecast 
                2.3.2.    Market Share Analysis 
       2.4.    Assumptions for the Study 
       2.5.    Limitations for the Study 

3.    Executive Summary 

4.    Market Insights 
       4.1.    Introduction 
       4.2.    Drivers 
                4.2.1.    Growing Prevalence of Chronic and Infectious Diseases 
                4.2.2.    Technological Advancements in Immunoassays 
                4.2.3.    Increasing Use of Immunoassays in Oncology 
                4.2.4.    Role of Immunoassays in Drug and Alcohol Testing 
                4.2.5.    Impact of COVID-19 
       4.3.    Restraints 
                4.3.1.    Technical Impediments Concerned with Immunoassay kits 
                4.3.2.    Inadequate Reimbursement Policies for Immunoassays in the U.S. and Europe 
       4.4.    Opportunities 
                4.4.1.    Emerging Economies 
                4.4.2.    Integration of Microfluidics Technology in Immunoassays 

5.    Immunoassays Market – Regulatory Analysis 
       5.1.    North America 
       5.2.    Europe 
       5.3.    Asia-Pacific
       5.4.    Latin America and the Middle East & Africa 

6.    Global Immunoassays Market, by Product & Solution 
       6.1.    Introduction 
       6.2.    Immunoassay Kits & Reagents 
                6.2.1.    Elisa Kits & Reagents 
                6.2.2.    Rapid Test Kits & Reagents 
                6.2.3.    Western Blot Kits & Reagents 
                6.2.4.    Elispot Kits & Reagents 
                6.2.5.    Other Immunoassay Kits & Reagents 
       6.3.    Immunoassay Analyzers 
       6.4.    Immunoassay Software & Services 

7.    Global Immunoassays Market, by Platform 
       7.1.    Introduction 
       7.2.    Chemiluminescence Immunoassay 
       7.3.    Fluorescence Immunoassay 
       7.4.    Colorimetric Immunoassay 
       7.5.    Radioimmunoassay 
       7.6.    Other Immunoassay Platforms

8.    Global Immunoassays Market, by Application 
       8.1.    Introduction 
       8.2.    Infectious Diseases 
       8.3.    Oncology 
       8.4.    Endocrinology 
       8.5.    Cardiology 
       8.6.    Bone and Mineral Diseases        
       8.7.    Autoimmune Disorders 
       8.8.    Other Applications 

9.    Global Immunoassays Market, by End User 
       9.1.    Introduction 
       9.2.    Diagnostic Reference Laboratories 
       9.3.    Hospitals & Clinics 
       9.4.    Pharmaceutical and Biotechnology Companies 
       9.5.    Academic and Research Institutions 
       9.6.    Other End Users 

10.    Immunoassays Market, by Geography 
         10.1.    Introduction 
         10.2.    North America 
                    10.2.1.    U.S. 
                    10.2.2.    Canada 
         10.3.    Europe 
                    10.3.1.    Germany 
                    10.3.2.    Italy 
                    10.3.3.    France 
                    10.3.4.    U.K. 
                    10.3.5.    Spain 
                    10.3.6.    Rest of Europe (RoE) 
         10.4.    Asia-Pacific 
                    10.4.1.    Japan 
                    10.4.2.    China 
                    10.4.3.    India 
                    10.4.4.    Australia 
                    10.4.5.    Indonesia 
                    10.4.6.    Rest of Asia-Pacific (RoAPAC) 
         10.5.    Latin America 
                    10.5.1.    Brazil 
                    10.5.2.    Mexico 
                    10.5.3.    Rest of Latin America 
         10.6.    Middle East and Africa 

11.    Competitive Landscape 
         11.1.    Introduction 
         11.2.    Key Growth Strategies 
         11.3.    Competitive Benchmarking 
         11.4.    Market Share Analysis (2020) 
                    11.4.1.    F. Hoffmann-La Roche AG (SWITZERLAND) 
                    11.4.2.    Abbott Laboratories (U.S.) 
                    11.4.3.    Siemens Healthineers AG (GERMANY) 

12.    Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
         12.1.    F. Hoffmann-La Roche AG 
         12.2.    Siemens Healthineers AG (Subsidiary of Siemens AG) 
         12.3.    Abbott Laboratories 
         12.4.    Danaher Corporation 
         12.5.    Sysmex Corporation 
         12.6.    bioMérieux SA
         12.7.    Thermo Fisher Scientific Inc. 
         12.8.    Becton, Dickinson and Company 
         12.9.    Merck KGaA          
         12.10.    Bio-Rad Laboratories, Inc. 
         12.11.    Agilent Technologies, Inc. 
         12.12.    PerkinElmer, Inc. 

13.    Appendix 
         13.1.    Questionnaire 
         13.2.    Available Customization 

List of Tables

Table 1    Global Immunoassays Market Drivers: Impact Analysis (2021-2028) 
Table 2    Immunoassays for Tumor Markers Analysis 
Table 3    Immunological Tests Used to Detect SARS-Cov-2 Virus 
Table 4    Global Immunoassays Market Restraints: Impact Analysis (2021-2028) 
Table 5    Common Problems with Immunoassays 
Table 6    Reimbursement for Few Immunoassays in the U.S. 
Table 7    Microfluidic Heterogeneous Immunoassays for Protein Biomarkers Quantitation 
Table 8    Policy/Guidelines/Standards in Europe 
Table 9    Immunoassay Regulations in Asia-Pacific Region 
TABLE 10    Immunoassay Regulations in the Rest of the World 
Table 11    GLOBAL Immunoassays Market Size, by Product & Solution, 2019–2028 
(USD MILLION) 
Table 12    Types of Reagents Used in Immunoassays 
Table 13    Global Immunoassay Kits & Reagents Market Size, by Type, 2019–2028 
(USD Million) 
Table 14    Immunoassay Kits & Reagents Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 15    Key Companies Offering Elisa Kits & Reagents 
Table 16    ELISA Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 17    Key Companies Offering Rapid Test Kits & Reagents 
Table 18    Rapid Test Kits & Reagents Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 19    Key Companies Offering Western Blot Kits & Reagents 
Table 20    Western Blot Kits & Reagents Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 21    ELISPOT Vs. Conventional ELISA 
Table 22    Key Companies Offering ELISPOT Kits & Reagents 
Table 23    ELISPOT Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 24    Other Immunoassay Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 25    Some of the Key Companies Offering Immunoassay Analyzers 
Table 26    Immunoassay Analyzers Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 27    Some of the Key Commercial Immunoassay Software Available in the Global Market 
Table 28    Immunoassay Software & Services Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 29    GLOBAL Immunoassays Market Size, by Platform, 2019–2028 (USD MILLION) 
Table 30    Key Companies Offering Chemiluminescence Immunoassay Products 
Table 31    Chemiluminescence Immunoassay Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 32    Key Companies Offering Fluorescence Immunoassay Products 
Table 33    Fluorescence Immunoassay Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 34    Key Companies Offering Colorimetric Immunoassay Products 
Table 35    Colorimetric Immunoassay Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 36    Key Companies Offering Radioimmunoassay Kits & Reagents 
Table 37    Radioimmunoassay Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 38    Other Immunoassay Platforms Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 39    Global Immunoassays Market Size, by Application, 2019–2028 (USD Million) 
Table 40    Rapid Tests for Detecting COVID-19 
Table 41    Global HIV Prevalence, by Region (2019) 
Table 42    Immunoassays Market Size for Infectious Diseases, by Country/Region, 2019–2028 (USD Million) 
Table 43    Global Cancer Incidence and Mortality, by Type (2020) 
Table 44    Immunoassays Market Size for Oncology, by Country/Region, 2019–2028 
(USD Million) 
Table 45    Immunoassays Market Size for Endocrinology, by Country/Region, 2019–2028 
(USD Million) 
Table 46    Immunoassays Market Size for Cardiology, by Country/Region, 2019–2028 
(USD Million) 
Table 47    Immunoassays Market Size for Bone and Mineral Diseases, by Country/Region, 2019–2028 (USD Million) 
Table 48    Immunoassays Market Size for Autoimmune Disorders, by Country/Region, 
2019–2028 (USD Million) 
Table 49    Immunoassays Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million) 
Table 50    Global Immunoassays Market Size, by End User, 2019–2028 (USD Million) 
Table 51    Immunoassays Market Size for Diagnostic Reference Laboratories, 
By Country/Region, 2019–2028 (USD Million) 
Table 52    Immunoassays Market Size for Hospitals & Clinics, by Country/Region, 
2019–2028 (USD MILLION) 
Table 53    Immunoassays Market Size for Pharmaceutical and Biotechnology Companies, 
By Country/Region, 2019–2028 (USD Million) 
Table 54    Immunoassays Market Size for Academic and Research Institutions, 
By Country/Region, 2019–2028 (USD Million) 
Table 55    Immunoassays Market Size for Other End Users, by Country/Region, 2019–2028 (USD Million) 
Table 56    Global Immunoassays Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 57    North America: Immunoassays Market Size, by Country, 2019 – 2028 
(USD Million) 
Table 58    North America: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million) 
Table 59    North America: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million) 
Table 60    North America: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 61    North America: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 62    North America: Immunoassays Market Size, by End User, 2019 – 2028 
(USD Million) 
Table 63    Recent Lateral Flow Assays Product Launches for COVID-19 Testing in U.S. 
Table 64    U.S.: Immunoassays Market Size, by Product & Solution, 2019 – 2028 
(USD Million) 
Table 65    U.S.: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 66    U.S.: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 67    U.S.: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 68    U.S.: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 69    Canada: Immunoassays Market Size, by Product & Solution, 2019 – 2028 
(USD Million) 
Table 70    Canada: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 71    Canada: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 72    Canada: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 73    Canada: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 74    Europe: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million) 
Table 75    Europe: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 76    Europe: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 77    Europe: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 78    Europe: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 79    Europe: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 80    Recent Immunoassay Kits Launched for COVID-19 Testing In Germany 
Table 81    Germany: Immunoassays Market Size, By Product & Solutions, 2019 – 2028 
(USD Million) 
Table 82    Germany: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 83    Germany: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 84    Germany: Immunoassay Market Size, by Application, 2019 – 2028 (USD Million) 
Table 85    Germany: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 86    Number Of Cancer Cases, (2019 vs. 2040) 
Table 87    Italy: COVID-19 Cases 
Table 88    Italy: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 89    Italy: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 90    Italy: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 91    Italy: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 92    Italy: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 93    France: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 94    France: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 95    France: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 96    France: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 97    France: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 98    Number of Acute Respiratory Illness Outbreaks in the U.K. by Institution Type: 2015-2019 
Table 99    U.K.: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 100    U.K.: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 101    U.K.: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 102    U.K.: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 103    U.K.: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
 Table 104    Spain: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 105    Spain: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD MILLION) 
Table 106    Spain: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 107    Spain: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 108    Spain: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 109    COVID-19 Cases in European Countries 
Table 110    RoE: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 111    RoE: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 112    RoE: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 113    RoE: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 114    RoE: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 115    Asia-Pacific: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million) 
Table 116    Asia-Pacific: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million)
Table 117    Asia-Pacific: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million) 
Table 118    Asia-Pacific: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 119    Asia-Pacific: Immunoassay Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 120    Asia-Pacific: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 121    Japan: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 122    Japan: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 123    Japan: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 124    Japan: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 125    Japan: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 126    China: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 127    China: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 128    China: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 129    China: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 130    China: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 131    India: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 132    INDIA: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 133    India: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 134    India: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 135    India: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 136    Australia: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 137    Australia: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 138    Australia: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 139    Australia: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 140    Australia: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 141    Indonesia: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 142    Indonesia: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 143    Indonesia: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 144    Indonesia: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 145    Indonesia: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 146    RoAPAC: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 147    RoAPAC: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 148    RoAPAC: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 149    RoAPAC: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 150    RoAPAC: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 151    Latin America: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million) 
Table 152    Latin America: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million) 
Table 153    Latin America: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million) 
Table 154    Latin America: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 155    Latin America: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 156    Latin America: Immunoassays Market Size, by End User, 2019 – 2028 
(USD Million) 
Table 157    Brazil: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 158    Brazil: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 159    Brazil: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 160    Brazil: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 161    Brazil: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 162    Some Immunoassays Validated by the National Institute for Epidemiological Diagnosis and Reference (Indre) in Mexico 
Table 163    Mexico: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 164    Mexico: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 165    Mexico: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 166    Mexico: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 167    Mexico: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 168    Disease Prevalence and top Causes of Deaths (2019) 
Table 169    Rest of Latin America: Immunoassays Market Size, by Product & Solutions, 
2019 – 2028 (USD Million) 
Table 170    Rest of Latin America: Immunoassay Kits and Reagents Market Size, by Type, 
2019 – 2028 (USD Million) 
Table 171    Rest of Latin America: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 172    Rest of Latin America: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 173    Rest of Latin America: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 174    Middle East & Africa: Immunoassays Market Size, by Product & Solutions, 
2019 – 2028 (USD Million) 
Table 175    Middle East & Africa: Immunoassays Kits and Reagents Market Size, by Type, 
2019 – 2028 (USD Million) 
Table 176    Middle East & Africa: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 177    Middle East & Africa: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 178    Middle East & Africa: Immunoassays Market Size, by End User, 2019 – 2028 
(USD Million) 
Table 179    Recent Developments, by Company, 2018—2021 

List of Figures

Figure 1    Research Process 
Figure 2    Key Secondary Sources 
Figure 3    Primary Research Techniques 
Figure 4    Key Executives Interviewed 
Figure 5    Breakdown of Primary Interviews (Supply-Side & Demand-Side) 
Figure 6    Market Size Estimation 
Figure 7    Global Immunoassays Market Size, by Product & Solution, 2021 vs. 2028 
(USD Million) 
Figure 8    Global Immunoassays Market Size, by Platform, 2021 vs. 2028 (USD Million) 
Figure 9    Global Immunoassays Market Size, by Application, 2021 vs. 2028 (USD Million) 
Figure 10    Diagnostic Reference Laboratories to Dominate the Immunoassays Market, 
by End User (2021 vs. 2028) 
Figure 11    Immunoassays Market, by Region 
Figure 12    Market Dynamics 
Figure 13    Global Diabetes Prevalence by Age and Sex in 2019 
Figure 14    Global Immunoassays Market Size, by Product & Solution, 2021–2028 (USD Million) 
Figure 15    Number of People Living with HIV Worldwide, 2015–2019 (Million) 
Figure 16    Global Immunoassays Market Size, by Platform, 2021–2028 (USD Million) 
Figure 17    Global Immunoassays Market Size, by Application, 2021–2028 (USD Million) 
Figure 18    Global Immunoassays Market Size, by End User, 2021–2028 (USD Million) 
Figure 19    Hospital Admissions Due to COVID-19 (2020–2021) 
Figure 20    Global Immunoassays Market, by Region, 2021 – 2028 (USD Million) 
Figure 21    Geographic Snapshot: North American Immunoassays Market 
Figure 22    Geographic Snapshot: European Immunoassays Market 
Figure 23    France: The Share of Older People (65 Years and Above), 2012-2050 
Figure 24    Geographic Snapshot: Asia-Pacific Immunoassays Market 
Figure 25    Japan: Share of Geriatric Population in total Population (65 And Over) 
Figure 26    Key Growth Strategies Adopted by Leading Players, 2018—2021 
Figure 27    Immunoassays Market: Competitive Benchmarking, by Product 
Figure 28    Market Share Analysis: Immunoassays Industry, 2020 
Figure 29    F. Hoffmann-La Roche AG: Financial Overview, 2020 
Figure 30    Siemens Healthineers AG.: Financial Overview, 2020 
Figure 31    Abbott Laboratories.: Financial Overview, 2020 
Figure 32    Danaher Corporation: Financial Overview, 2020 
Figure 33    Sysmex Corporation.: Financial Overview, 2020 
Figure 34    bioMérieux SA: Financial Overview, 2020 
Figure 35    Thermo Fisher Scientific Inc: Financial Overview, 2020 
Figure 36    Becton, Dickinson and Company: Financial Overview, 2020 
Figure 37    Merck KGaA: Financial Overview, 2020 
Figure 38    Bio-Rad Laboratories, Inc.: Financial Overview, 2020 
Figure 39    Agilent Technologies, Inc.: Financial Overview, 2020 
Figure 40    PerkinElmer, Inc.: Financial Overview, 2021 

  Request Sample

1.    Introduction 
       1.1.    Market Definition 
       1.2.    Market Ecosystem 
       1.3.    Currency 
       1.4.    Key Stakeholders 

2.    Research Methodology 
       2.1.    Research Process 
       2.2.    Data Collection & Validation 
                 2.2.1.    Secondary Research 
                2.2.2.    Primary Research 
       2.3.    Market Assessment 
                2.3.1.    Market Size Estimation 
                             2.3.1.1.    Bottom-Up Approach 
                             2.3.1.2.    Top-Down Approach 
                             2.3.1.3.    Growth forecast 
                2.3.2.    Market Share Analysis 
       2.4.    Assumptions for the Study 
       2.5.    Limitations for the Study 

3.    Executive Summary 

4.    Market Insights 
       4.1.    Introduction 
       4.2.    Drivers 
                4.2.1.    Growing Prevalence of Chronic and Infectious Diseases 
                4.2.2.    Technological Advancements in Immunoassays 
                4.2.3.    Increasing Use of Immunoassays in Oncology 
                4.2.4.    Role of Immunoassays in Drug and Alcohol Testing 
                4.2.5.    Impact of COVID-19 
       4.3.    Restraints 
                4.3.1.    Technical Impediments Concerned with Immunoassay kits 
                4.3.2.    Inadequate Reimbursement Policies for Immunoassays in the U.S. and Europe 
       4.4.    Opportunities 
                4.4.1.    Emerging Economies 
                4.4.2.    Integration of Microfluidics Technology in Immunoassays 

5.    Immunoassays Market – Regulatory Analysis 
       5.1.    North America 
       5.2.    Europe 
       5.3.    Asia-Pacific
       5.4.    Latin America and the Middle East & Africa 

6.    Global Immunoassays Market, by Product & Solution 
       6.1.    Introduction 
       6.2.    Immunoassay Kits & Reagents 
                6.2.1.    Elisa Kits & Reagents 
                6.2.2.    Rapid Test Kits & Reagents 
                6.2.3.    Western Blot Kits & Reagents 
                6.2.4.    Elispot Kits & Reagents 
                6.2.5.    Other Immunoassay Kits & Reagents 
       6.3.    Immunoassay Analyzers 
       6.4.    Immunoassay Software & Services 

7.    Global Immunoassays Market, by Platform 
       7.1.    Introduction 
       7.2.    Chemiluminescence Immunoassay 
       7.3.    Fluorescence Immunoassay 
       7.4.    Colorimetric Immunoassay 
       7.5.    Radioimmunoassay 
       7.6.    Other Immunoassay Platforms

8.    Global Immunoassays Market, by Application 
       8.1.    Introduction 
       8.2.    Infectious Diseases 
       8.3.    Oncology 
       8.4.    Endocrinology 
       8.5.    Cardiology 
       8.6.    Bone and Mineral Diseases        
       8.7.    Autoimmune Disorders 
       8.8.    Other Applications 

9.    Global Immunoassays Market, by End User 
       9.1.    Introduction 
       9.2.    Diagnostic Reference Laboratories 
       9.3.    Hospitals & Clinics 
       9.4.    Pharmaceutical and Biotechnology Companies 
       9.5.    Academic and Research Institutions 
       9.6.    Other End Users 

10.    Immunoassays Market, by Geography 
         10.1.    Introduction 
         10.2.    North America 
                    10.2.1.    U.S. 
                    10.2.2.    Canada 
         10.3.    Europe 
                    10.3.1.    Germany 
                    10.3.2.    Italy 
                    10.3.3.    France 
                    10.3.4.    U.K. 
                    10.3.5.    Spain 
                    10.3.6.    Rest of Europe (RoE) 
         10.4.    Asia-Pacific 
                    10.4.1.    Japan 
                    10.4.2.    China 
                    10.4.3.    India 
                    10.4.4.    Australia 
                    10.4.5.    Indonesia 
                    10.4.6.    Rest of Asia-Pacific (RoAPAC) 
         10.5.    Latin America 
                    10.5.1.    Brazil 
                    10.5.2.    Mexico 
                    10.5.3.    Rest of Latin America 
         10.6.    Middle East and Africa 

11.    Competitive Landscape 
         11.1.    Introduction 
         11.2.    Key Growth Strategies 
         11.3.    Competitive Benchmarking 
         11.4.    Market Share Analysis (2020) 
                    11.4.1.    F. Hoffmann-La Roche AG (SWITZERLAND) 
                    11.4.2.    Abbott Laboratories (U.S.) 
                    11.4.3.    Siemens Healthineers AG (GERMANY) 

12.    Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
         12.1.    F. Hoffmann-La Roche AG 
         12.2.    Siemens Healthineers AG (Subsidiary of Siemens AG) 
         12.3.    Abbott Laboratories 
         12.4.    Danaher Corporation 
         12.5.    Sysmex Corporation 
         12.6.    bioMérieux SA
         12.7.    Thermo Fisher Scientific Inc. 
         12.8.    Becton, Dickinson and Company 
         12.9.    Merck KGaA          
         12.10.    Bio-Rad Laboratories, Inc. 
         12.11.    Agilent Technologies, Inc. 
         12.12.    PerkinElmer, Inc. 

13.    Appendix 
         13.1.    Questionnaire 
         13.2.    Available Customization 

List of Tables

Table 1    Global Immunoassays Market Drivers: Impact Analysis (2021-2028) 
Table 2    Immunoassays for Tumor Markers Analysis 
Table 3    Immunological Tests Used to Detect SARS-Cov-2 Virus 
Table 4    Global Immunoassays Market Restraints: Impact Analysis (2021-2028) 
Table 5    Common Problems with Immunoassays 
Table 6    Reimbursement for Few Immunoassays in the U.S. 
Table 7    Microfluidic Heterogeneous Immunoassays for Protein Biomarkers Quantitation 
Table 8    Policy/Guidelines/Standards in Europe 
Table 9    Immunoassay Regulations in Asia-Pacific Region 
TABLE 10    Immunoassay Regulations in the Rest of the World 
Table 11    GLOBAL Immunoassays Market Size, by Product & Solution, 2019–2028 
(USD MILLION) 
Table 12    Types of Reagents Used in Immunoassays 
Table 13    Global Immunoassay Kits & Reagents Market Size, by Type, 2019–2028 
(USD Million) 
Table 14    Immunoassay Kits & Reagents Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 15    Key Companies Offering Elisa Kits & Reagents 
Table 16    ELISA Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 17    Key Companies Offering Rapid Test Kits & Reagents 
Table 18    Rapid Test Kits & Reagents Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 19    Key Companies Offering Western Blot Kits & Reagents 
Table 20    Western Blot Kits & Reagents Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 21    ELISPOT Vs. Conventional ELISA 
Table 22    Key Companies Offering ELISPOT Kits & Reagents 
Table 23    ELISPOT Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 24    Other Immunoassay Kits & Reagents Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 25    Some of the Key Companies Offering Immunoassay Analyzers 
Table 26    Immunoassay Analyzers Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 27    Some of the Key Commercial Immunoassay Software Available in the Global Market 
Table 28    Immunoassay Software & Services Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 29    GLOBAL Immunoassays Market Size, by Platform, 2019–2028 (USD MILLION) 
Table 30    Key Companies Offering Chemiluminescence Immunoassay Products 
Table 31    Chemiluminescence Immunoassay Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 32    Key Companies Offering Fluorescence Immunoassay Products 
Table 33    Fluorescence Immunoassay Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 34    Key Companies Offering Colorimetric Immunoassay Products 
Table 35    Colorimetric Immunoassay Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 36    Key Companies Offering Radioimmunoassay Kits & Reagents 
Table 37    Radioimmunoassay Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 38    Other Immunoassay Platforms Market Size, by Country/Region, 2019–2028 
(USD Million) 
Table 39    Global Immunoassays Market Size, by Application, 2019–2028 (USD Million) 
Table 40    Rapid Tests for Detecting COVID-19 
Table 41    Global HIV Prevalence, by Region (2019) 
Table 42    Immunoassays Market Size for Infectious Diseases, by Country/Region, 2019–2028 (USD Million) 
Table 43    Global Cancer Incidence and Mortality, by Type (2020) 
Table 44    Immunoassays Market Size for Oncology, by Country/Region, 2019–2028 
(USD Million) 
Table 45    Immunoassays Market Size for Endocrinology, by Country/Region, 2019–2028 
(USD Million) 
Table 46    Immunoassays Market Size for Cardiology, by Country/Region, 2019–2028 
(USD Million) 
Table 47    Immunoassays Market Size for Bone and Mineral Diseases, by Country/Region, 2019–2028 (USD Million) 
Table 48    Immunoassays Market Size for Autoimmune Disorders, by Country/Region, 
2019–2028 (USD Million) 
Table 49    Immunoassays Market Size for Other Applications, by Country/Region, 2019–2028 (USD Million) 
Table 50    Global Immunoassays Market Size, by End User, 2019–2028 (USD Million) 
Table 51    Immunoassays Market Size for Diagnostic Reference Laboratories, 
By Country/Region, 2019–2028 (USD Million) 
Table 52    Immunoassays Market Size for Hospitals & Clinics, by Country/Region, 
2019–2028 (USD MILLION) 
Table 53    Immunoassays Market Size for Pharmaceutical and Biotechnology Companies, 
By Country/Region, 2019–2028 (USD Million) 
Table 54    Immunoassays Market Size for Academic and Research Institutions, 
By Country/Region, 2019–2028 (USD Million) 
Table 55    Immunoassays Market Size for Other End Users, by Country/Region, 2019–2028 (USD Million) 
Table 56    Global Immunoassays Market Size, by Country/Region, 2019–2028 (USD Million) 
Table 57    North America: Immunoassays Market Size, by Country, 2019 – 2028 
(USD Million) 
Table 58    North America: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million) 
Table 59    North America: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million) 
Table 60    North America: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 61    North America: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 62    North America: Immunoassays Market Size, by End User, 2019 – 2028 
(USD Million) 
Table 63    Recent Lateral Flow Assays Product Launches for COVID-19 Testing in U.S. 
Table 64    U.S.: Immunoassays Market Size, by Product & Solution, 2019 – 2028 
(USD Million) 
Table 65    U.S.: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 66    U.S.: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 67    U.S.: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 68    U.S.: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 69    Canada: Immunoassays Market Size, by Product & Solution, 2019 – 2028 
(USD Million) 
Table 70    Canada: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 71    Canada: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 72    Canada: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 73    Canada: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 74    Europe: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million) 
Table 75    Europe: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 76    Europe: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 77    Europe: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 78    Europe: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 79    Europe: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 80    Recent Immunoassay Kits Launched for COVID-19 Testing In Germany 
Table 81    Germany: Immunoassays Market Size, By Product & Solutions, 2019 – 2028 
(USD Million) 
Table 82    Germany: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 83    Germany: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 84    Germany: Immunoassay Market Size, by Application, 2019 – 2028 (USD Million) 
Table 85    Germany: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 86    Number Of Cancer Cases, (2019 vs. 2040) 
Table 87    Italy: COVID-19 Cases 
Table 88    Italy: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 89    Italy: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 90    Italy: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 91    Italy: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 92    Italy: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 93    France: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 94    France: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 95    France: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 96    France: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 97    France: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 98    Number of Acute Respiratory Illness Outbreaks in the U.K. by Institution Type: 2015-2019 
Table 99    U.K.: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 100    U.K.: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 101    U.K.: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 102    U.K.: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 103    U.K.: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
 Table 104    Spain: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 105    Spain: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD MILLION) 
Table 106    Spain: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 107    Spain: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 108    Spain: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 109    COVID-19 Cases in European Countries 
Table 110    RoE: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 111    RoE: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 112    RoE: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 113    RoE: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 114    RoE: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 115    Asia-Pacific: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million) 
Table 116    Asia-Pacific: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million)
Table 117    Asia-Pacific: Immunoassays Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million) 
Table 118    Asia-Pacific: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 119    Asia-Pacific: Immunoassay Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 120    Asia-Pacific: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 121    Japan: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 122    Japan: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 123    Japan: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 124    Japan: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 125    Japan: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 126    China: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 127    China: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 128    China: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 129    China: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 130    China: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 131    India: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 132    INDIA: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 133    India: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 134    India: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 135    India: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 136    Australia: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 137    Australia: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 138    Australia: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 139    Australia: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 140    Australia: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 141    Indonesia: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 142    Indonesia: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 143    Indonesia: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 144    Indonesia: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 145    Indonesia: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 146    RoAPAC: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 147    RoAPAC: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 148    RoAPAC: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 149    RoAPAC: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 150    RoAPAC: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 151    Latin America: Immunoassays Market Size, by Country, 2019 – 2028 (USD Million) 
Table 152    Latin America: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 (USD Million) 
Table 153    Latin America: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 (USD Million) 
Table 154    Latin America: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 155    Latin America: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 156    Latin America: Immunoassays Market Size, by End User, 2019 – 2028 
(USD Million) 
Table 157    Brazil: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 158    Brazil: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 159    Brazil: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 160    Brazil: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 161    Brazil: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 162    Some Immunoassays Validated by the National Institute for Epidemiological Diagnosis and Reference (Indre) in Mexico 
Table 163    Mexico: Immunoassays Market Size, by Product & Solutions, 2019 – 2028 
(USD Million) 
Table 164    Mexico: Immunoassay Kits and Reagents Market Size, by Type, 2019 – 2028 
(USD Million) 
Table 165    Mexico: Immunoassays Market Size, by Platform, 2019 – 2028 (USD Million) 
Table 166    Mexico: Immunoassays Market Size, by Application, 2019 – 2028 (USD Million) 
Table 167    Mexico: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 168    Disease Prevalence and top Causes of Deaths (2019) 
Table 169    Rest of Latin America: Immunoassays Market Size, by Product & Solutions, 
2019 – 2028 (USD Million) 
Table 170    Rest of Latin America: Immunoassay Kits and Reagents Market Size, by Type, 
2019 – 2028 (USD Million) 
Table 171    Rest of Latin America: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 172    Rest of Latin America: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 173    Rest of Latin America: Immunoassays Market Size, by End User, 2019 – 2028 (USD Million) 
Table 174    Middle East & Africa: Immunoassays Market Size, by Product & Solutions, 
2019 – 2028 (USD Million) 
Table 175    Middle East & Africa: Immunoassays Kits and Reagents Market Size, by Type, 
2019 – 2028 (USD Million) 
Table 176    Middle East & Africa: Immunoassays Market Size, by Platform, 2019 – 2028 
(USD Million) 
Table 177    Middle East & Africa: Immunoassays Market Size, by Application, 2019 – 2028 
(USD Million) 
Table 178    Middle East & Africa: Immunoassays Market Size, by End User, 2019 – 2028 
(USD Million) 
Table 179    Recent Developments, by Company, 2018—2021 

List of Figures

Figure 1    Research Process 
Figure 2    Key Secondary Sources 
Figure 3    Primary Research Techniques 
Figure 4    Key Executives Interviewed 
Figure 5    Breakdown of Primary Interviews (Supply-Side & Demand-Side) 
Figure 6    Market Size Estimation 
Figure 7    Global Immunoassays Market Size, by Product & Solution, 2021 vs. 2028 
(USD Million) 
Figure 8    Global Immunoassays Market Size, by Platform, 2021 vs. 2028 (USD Million) 
Figure 9    Global Immunoassays Market Size, by Application, 2021 vs. 2028 (USD Million) 
Figure 10    Diagnostic Reference Laboratories to Dominate the Immunoassays Market, 
by End User (2021 vs. 2028) 
Figure 11    Immunoassays Market, by Region 
Figure 12    Market Dynamics 
Figure 13    Global Diabetes Prevalence by Age and Sex in 2019 
Figure 14    Global Immunoassays Market Size, by Product & Solution, 2021–2028 (USD Million) 
Figure 15    Number of People Living with HIV Worldwide, 2015–2019 (Million) 
Figure 16    Global Immunoassays Market Size, by Platform, 2021–2028 (USD Million) 
Figure 17    Global Immunoassays Market Size, by Application, 2021–2028 (USD Million) 
Figure 18    Global Immunoassays Market Size, by End User, 2021–2028 (USD Million) 
Figure 19    Hospital Admissions Due to COVID-19 (2020–2021) 
Figure 20    Global Immunoassays Market, by Region, 2021 – 2028 (USD Million) 
Figure 21    Geographic Snapshot: North American Immunoassays Market 
Figure 22    Geographic Snapshot: European Immunoassays Market 
Figure 23    France: The Share of Older People (65 Years and Above), 2012-2050 
Figure 24    Geographic Snapshot: Asia-Pacific Immunoassays Market 
Figure 25    Japan: Share of Geriatric Population in total Population (65 And Over) 
Figure 26    Key Growth Strategies Adopted by Leading Players, 2018—2021 
Figure 27    Immunoassays Market: Competitive Benchmarking, by Product 
Figure 28    Market Share Analysis: Immunoassays Industry, 2020 
Figure 29    F. Hoffmann-La Roche AG: Financial Overview, 2020 
Figure 30    Siemens Healthineers AG.: Financial Overview, 2020 
Figure 31    Abbott Laboratories.: Financial Overview, 2020 
Figure 32    Danaher Corporation: Financial Overview, 2020 
Figure 33    Sysmex Corporation.: Financial Overview, 2020 
Figure 34    bioMérieux SA: Financial Overview, 2020 
Figure 35    Thermo Fisher Scientific Inc: Financial Overview, 2020 
Figure 36    Becton, Dickinson and Company: Financial Overview, 2020 
Figure 37    Merck KGaA: Financial Overview, 2020 
Figure 38    Bio-Rad Laboratories, Inc.: Financial Overview, 2020 
Figure 39    Agilent Technologies, Inc.: Financial Overview, 2020 
Figure 40    PerkinElmer, Inc.: Financial Overview, 2021 

  Request Sample
Related Research